Cas:126-27-2 Oxethazaine manufacturer & supplier

Chemical Name:Oxethazaine

CAS.NO:126-27-2

Synonyms:2,2′-[(2-Hydroxyethyl)imino]bis[N-methyl-N-(2-methyl-1-phenyl-2-propanyl)acetamide];2,2′-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methylacetamide];Acetamide, 2,2′-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methyl-;N,N-Bis[N-methyl-N-phenyl-tert-butylacetamido]-b-hydroxyethylamine;EINECS 204-780-5;2,2′-[(2-Hydroxyethyl)imino]bis[N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide];MFCD00079202;2-[2-hydroxyethyl-[2-[methyl-(2-methyl-1-phenylpropan-2-yl)amino]-2-oxoethyl]amino]-N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide;oxethazine;2,2′-[(2-Hydroxyethyl)imino]bis[N(1,1-dimethyl-2-phenylethyl)-N-methylacetamide]

Molecular Formula:C₂₈H₄₁N₃O₃

Molecular Weight:467.643

HS Code:

Physical and Chemical Properties:

Melting point:104-105°C

Boiling point:630.4±55.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.558

PSA:64.09000

Exact Mass:467.314789

LogP:4.94

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 2,2′-[(2-Hydroxyethyl)imino]bis[N-methyl-N-(2-methyl-1-phenyl-2-propanyl)acetamide] chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,2′-[(2-Hydroxyethyl)imino]bis[N(1,1-dimethyl-2-phenylethyl)-N-methylacetamide] physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00079202 Use and application,oxethazine technical grade,usp/ep/jp grade.

Related News: When these modified cells are given back to the patient, they are transported in the bloodstream to the bone marrow where they start to make healthy red blood cells that produce beta-globin. The effects of Zynteglo are expected to last for the patient’s lifetime. benzoic acid-14C manufacturers Mene Pangalos, executive vice president, BioPharmaceuticals R&D, said: “The data being presented at EULAR add to the growing body of evidence for anifrolumab that demonstrate a compelling clinical profile with the potential to address significant unmet medical needs in this debilitating disease. 5-(Benzyloxy)-1H-pyrrolo[3,2-b]pyridine-2-carboxylic acid suppliers The development of various enabling technologies has been critical in expanding the potential of biocatalytic processing, as well as in promoting its uptake across the pharmaceutical industry. methyl 2-[1-(benzenesulfonyl)-5-methoxyindol-2-yl]-2-oxoacetate vendor & factory.